Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.218
-0.012 (-0.97%)
At close: Nov 4, 2024, 4:00 PM
1.200
-0.018 (-1.49%)
After-hours: Nov 4, 2024, 4:40 PM EST

Dermata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
22514--
Market Cap Growth
-74.47%-56.39%-65.84%---
Enterprise Value
-3-4-32--
Last Close Price
1.229.1598.16417.60--
PE Ratio
--0.23-0.47-0.72--
PB Ratio
0.250.340.821.43--
P/FCF Ratio
-0.17-0.34-0.56-2.55--
P/OCF Ratio
-0.17-0.34-0.56-2.55--
EV/EBITDA Ratio
----0.24--
EV/EBIT Ratio
0.340.560.32-0.24--
EV/FCF Ratio
0.440.700.35-0.33--
Debt / Equity Ratio
-----1.12-6.11
Debt / FCF Ratio
-----0.88-0.33
Quick Ratio
2.584.596.787.120.141.16
Current Ratio
2.734.917.537.660.161.20
Return on Equity (ROE)
-173.01%-125.96%-119.18%-228.09%--
Return on Assets (ROA)
-90.68%-67.36%-65.13%-80.31%-148.47%-
Return on Capital (ROIC)
-111.46%-81.22%-74.98%-93.76%-275.18%-
Earnings Yield
-533.63%-361.07%-194.17%-54.53%--
FCF Yield
-421.26%-296.87%-178.48%-39.29%--
Buyback Yield / Dilution
-373.37%-323.42%-156.86%---
Total Shareholder Return
-373.37%-323.42%-156.86%---
Source: S&P Capital IQ. Standard template. Financial Sources.